Carson Wealth (CWM LLC)
QTTB icon

Carson Wealth (CWM LLC)’s Q32 Bio QTTB Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio QTTB Stock Details QTTB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$250 Sell
39
-15
-28% -$71 ﹤0.01% 5516
2025
Q4 		$0 Sell
54
-165
-75% -$466 ﹤0.01% 5697
2025
Q3 		$0 Sell
219
-4,550
-95% -$8.74K ﹤0.01% 5600
2025
Q2 		$7K Buy
4,769
+1,310
+38% +$2.23K ﹤0.01% 4503
2025
Q1 		$6K Buy
3,459
+3,455
+86,375% +$9.3K ﹤0.01% 4414
2024
Q4 		$0 Sell
4
-1
-20% -$32 ﹤0.01% 5211
2024
Q3 		$0 Buy
+5
New +$184 ﹤0.01% 5212

Other funds holding QTTB

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
AVLSA
Atlas Venture Life Science Advisors Cambridge, Massachusetts $790M AUM 223.66% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
CG
Carlyle Group Washington, District of Columbia $10.6B AUM 11.25% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
ACA
Acorn Capital Advisors New York $352M AUM 299.18% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
S
Sanofi Paris, France $336M AUM 126.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Carson Wealth (CWM LLC)'s QTTB Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Q32 Bio (QTTB) stake by 28% in Q1 2026, selling an estimated $71 and leaving 39 shares worth $250. The position accounts for ﹤0.01% of the portfolio, ranked #5516.

Carson Wealth (CWM LLC) first reported a position in QTTB in Q3 2024 and has held it in 7 quarters since. The position peaked at $7K in Q2 2025. 54 funds tracked by Wall St. Rank hold QTTB as of Q1 2026.

  • Carson Wealth (CWM LLC) held 39 shares of Q32 Bio worth $250 as of Q1 2026.
  • Carson Wealth (CWM LLC) sold 15 Q32 Bio shares in Q1 2026, an estimated $71.
  • Q32 Bio made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5516 holding.
  • Carson Wealth (CWM LLC) first reported a position in Q32 Bio in Q3 2024 and has held it in 7 quarters since.
  • Carson Wealth (CWM LLC)'s Q32 Bio position peaked at $7K in Q2 2025.
  • 54 funds tracked by Wall St. Rank held Q32 Bio as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.